Celon Pharma SA (0RKX) Income Statement
Celon Pharma SA Income Statement
Last quarter (Q2 2026), Celon Pharma SA's total revenue was $53.65M, a decrease of 5.21% from the same quarter last year. In Q2, Celon Pharma SA's net income was $-30.59M. See Celon Pharma SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 209.80M | $ 176.62M | $ 213.92M | $ 161.91M | $ 196.09M | |
| $ -39.48M | $ 113.45M | $ 147.10M | $ 95.45M | $ 134.37M | |
| $ 17.28M | $ 150.26M | $ 174.34M | $ 14.12M | $ 144.82M | |
| Depreciation and Amortization | $ 46.28M | $ 51.86M | $ 50.02M | $ 44.09M | $ 41.34M |
| $ -10.48M | $ 14.96M | $ 32.71M | $ 9.32M | $ 27.81M | |
| $ -56.76M | $ -36.81M | $ -27.24M | $ -69.76M | $ -10.45M | |
| $ -2.21M | $ -2.56M | $ 7.27M | $ 890.00K | $ -4.63M | |
| $ -58.97M | $ -39.37M | $ -19.97M | $ -36.45M | $ -15.09M | |
| $ -79.36M | $ -34.45M | $ -28.12M | $ -39.28M | $ -11.61M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.47 | $ -0.66 | $ -0.55 | $ -0.77 | $ -0.25 |
| Diluted EPS | $ -1.47 | $ -0.66 | $ -0.55 | $ -0.77 | $ -0.25 |
| Weighted Average Shares Outstanding | 53.86M | 52.51M | 51.06M | 51.02M | 46.68M |
| Weighted Average Shares Outstanding (Diluted) | 53.86M | 52.52M | 51.06M | 51.02M | 46.68M |
Currency in PLN
